MK
ABBV icon

MASTERINVEST Kapitalanlage’s AbbVie ABBV Stock Holding History

MASTERINVEST Kapitalanlage’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.1M Buy
76,014
+2,133
+3% +$459K 1.64% 13
2026
Q1 		$16.1M Sell
73,881
-8,675
-11% -$1.92M 1.67% 11
2025
Q4 		$19M Sell
82,556
-82
-0.1% -$18.7K 1.8% 10
2025
Q3 		$19.1M Buy
82,638
+16,005
+24% +$3.26M 1.87% 10
2025
Q2 		$12.4M Buy
+66,633
New +$12.4M 1.3% 14

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

MASTERINVEST Kapitalanlage's ABBV Position: Q2 2026 in Review

MASTERINVEST Kapitalanlage increased its AbbVie (ABBV) stake by 2.9% in Q2 2026, buying an estimated $459K and bringing the position to 76,014 shares worth $19.1M. The position accounts for 1.64% of the portfolio, ranked #13.

MASTERINVEST Kapitalanlage first reported a position in ABBV in Q2 2025 and has held it in 5 quarters since. The position peaked at $19.1M in Q3 2025. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • MASTERINVEST Kapitalanlage held 76,014 shares of AbbVie worth $19.1M as of Q2 2026.
  • MASTERINVEST Kapitalanlage bought 2,133 AbbVie shares in Q2 2026, an estimated $459K.
  • AbbVie made up 1.64% of MASTERINVEST Kapitalanlage's portfolio in Q2 2026, its #13 holding.
  • MASTERINVEST Kapitalanlage first reported a position in AbbVie in Q2 2025 and has held it in 5 quarters since.
  • MASTERINVEST Kapitalanlage's AbbVie position peaked at $19.1M in Q3 2025.
  • 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on MASTERINVEST Kapitalanlage's 13F filing for Q2 2026, filed 17 Aug 2026.